Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Progression-free Survival”

292 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 292 results

Not applicableStudy completedNCT02392078
What this trial is testing

Laser Ablation of Abnormal Neurological Tissue Using Robotic NeuroBlate System

Who this might be right for
Metastatic Brain TumorPrimary Brain TumorEpileptic/Seizure Foci+1 more
Monteris Medical 1,153
Not applicableUnknownNCT03531931
What this trial is testing

Apatinib Combined With Capecitabine Second-line Treatment of Advanced Gastric Cancer: a Single-arm Exploratory Clinical Pilot Trial

Who this might be right for
Progression-free Survival;Progression-free Survival;Disease Control Rate; Safety
The First Affiliated Hospital of Xiamen University 20
Not applicableEnded earlyNCT02485353
What this trial is testing

Study of Vosaroxin and Cytarabine for the Treatment of Adults 60 Years of Age or Older With Previously Untreated AML

Who this might be right for
Leukemia, Myeloid, Acute
Hamid Sayar 2
Not applicableStudy completedNCT03439332
What this trial is testing

Multicentre Validation of How Vascular Biomarkers From Tumor Can Predict the Survival of the Patient With Glioblastoma

Who this might be right for
Glioblastoma
Juan M Garcia-Gomez 305
Testing effectiveness (Phase 2)Ended earlyNCT01116128
What this trial is testing

Dasatinib in Combination With Melphalan and Prednisone to Treat Relapsed and Refractory Multiple Myeloma Patients

Who this might be right for
Myeloma
Fondazione EMN Italy Onlus 8
Not applicableUnknownNCT04331912
What this trial is testing

PFS and OS of Patients With Advanced Neuroendocrine Cancer (NEN) After Systemic Treatment

Who this might be right for
Neuroendocrine Tumors
University of Warmia and Mazury 100
Not applicableLooking for participantsNCT07258043
What this trial is testing

Efficacy of Dose-Adjusted Regimen on Survival in Frail Adults With Acute Lymphoblastic Leukemia

Who this might be right for
Acute Lymphobkastic LeukemiaLeukemiaOverall Survival
Hospital General de Mexico 45
Not applicableEnded earlyNCT01277133
What this trial is testing

An Observational Study on The Correlation Between Time of Initiation of Avastin (Bevacizumab) Treatment And Progression-Free Survival in Patients With Metastatic Breast Cancer (CRONOS 2)

Who this might be right for
Breast Cancer
Hoffmann-La Roche 83
Not applicableUnknownNCT02002195
What this trial is testing

Modified Folinic Acid-Fluorouracil-Oxaliplatin Regimen + Capecitabine for Elderly With Metastatic Gastric Cancer

Who this might be right for
Metastatic Gastric Cancer
International Group of Endovascular Oncology 47
Not applicableStudy completedNCT03998332
What this trial is testing

Overall Survival of Large Cell Neuroendocrine Lung Cancer Patients - a Retrospective Study

Who this might be right for
Survival Outcomes of Patients With Pulmonary LCNEC
Jaroslaw B. Cwikla, MD, PhD, Professor UWM 132
Testing effectiveness (Phase 2)Looking for participantsNCT04933669
What this trial is testing

Prospective Multicenter Clinical Study of Neoadjuvant Imatinib Mesylate for Gastrointestinal Stromal Tumors

Who this might be right for
Progression-free SurvivalGastrointestinal Stromal TumorNeoadjuvant
First Affiliated Hospital of Zhejiang University 122
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07591831
What this trial is testing

Liposomal Irinotecan Plus Enlonstobart for Platinum-Resistant Recurrent Ovarian Cancer

Who this might be right for
Platinum-resistant Recurrent Ovarian CancerFallopian Tube CancersEpithelial Ovarian Cancer+1 more
Tianjin Medical University Cancer Institute and Hospital 30
Testing effectiveness (Phase 2)Study completedNCT00842114
What this trial is testing

Rituximab and CVP Plus Interferon for Follicular Non Hodgkins Lymphoma (NHL)

Who this might be right for
Non-Hodgkin's Lymphoma
Fundación Leucemia y Linfoma, Spain 50
Testing effectiveness (Phase 2)Study completedNCT00520403
What this trial is testing

Avastin (Bevacizumab) in Combination With Standard Therapy in Patients With Metastatic Renal Cell Cancer.

Who this might be right for
Renal Cell Cancer
Hoffmann-La Roche 25
Not applicableStudy completedNCT05673967
What this trial is testing

Real-World Clinical Outcomes in Patients With Relapsed/Refractory Multiple Myeloma

Who this might be right for
Relapsed and Refractory Multiple Myeloma (RRMM)
Regeneron Pharmaceuticals 62
Testing effectiveness (Phase 2)Ended earlyNCT00474188
What this trial is testing

Evaluate Lenalidomide Combined With Dexamethasone in Relapsed or Refractory Diffuse Large B-Cell Lymphoma

Who this might be right for
Diffuse Large B-cell Lymphoma
Celgene Corporation 26
Not applicableStudy completedNCT05796700
What this trial is testing

Microwave Ablation Versus Laparoscopic Hepatectomy for 3-5cm Hepatocellular Carcinoma

Who this might be right for
Overall SurvivalProgression-free SurvivalCost
Chinese PLA General Hospital 1,585
Not applicableLooking for participantsNCT07394062
What this trial is testing

Real-World Comparison of Chemo-Immunotherapy Regimens in Metastatic NSCLC With PD-L1 <50% (ALCG-01)

Who this might be right for
Nonsmall Cell Lung Cancer, Stage IVMetastatic Nonsmall Cell Lung Cancer
Gazi University 400
Testing effectiveness (Phase 2)Study completedNCT00846027
What this trial is testing

Avastin (Bevacizumab) in Combination With Taxane-based Chemotherapy as First Line Treatment in Patients With HER-2 Negative Breast Cancer

Who this might be right for
Breast Cancer
Hoffmann-La Roche 90
Not applicableLooking for participantsNCT06215495
What this trial is testing

A Novel Target Delineation Scheme in High-grade Glioma Patients: a Randomized Single-blind Clinical Trial

Who this might be right for
Radiation ToxicityMRI Simulated PositioningHigh Grade Glioma+2 more
Zhujiang Hospital 88
Load More Results